N-LEVO – 500

N-LEVO – 500 by Floriwa Labs is a broad-spectrum antibiotic formulation containing Levofloxacin 500 mg, widely prescribed for the treatment of various bacterial infections. Levofloxacin belongs to the fluoroquinolone class of antibiotics and works by inhibiting bacterial DNA replication, thereby stopping the growth and spread of infection-causing bacteria.

N-LEVO – 500 is manufactured under strict quality standards to ensure high efficacy, safety, and consistent therapeutic results. It is commonly recommended by healthcare professionals for respiratory tract infections, urinary tract infections, skin infections, and other bacterial conditions.

Indications

N-LEVO – 500 is indicated for the treatment of:

• Lower respiratory tract infections

• Acute sinusitis

• Urinary tract infections (UTIs)

• Prostatitis

• Skin and soft tissue infections

• Typhoid fever

• Certain gastrointestinal bacterial infections

Uses

• Effective against Gram-positive and Gram-negative bacteria

• Provides fast symptomatic relief

• Reduces bacterial load effectively

• Suitable for moderate to severe bacterial infections

• Convenient once-daily dosage (as prescribed)

Key Benefits

• Broad-spectrum antibacterial coverage

• High bioavailability for better absorption

• Rapid onset of action

• Clinically proven molecule

• Trusted quality from Floriwa Labs

Dosage & Administration

The dosage of N-LEVO – 500 should be taken strictly as prescribed by a registered medical practitioner. Typically, one tablet daily or as directed by the physician depending on the severity and type of infection. The tablet should be swallowed whole with water and may be taken with or without food.

Precautions

• Not recommended for viral infections

• Use cautiously in patients with kidney disorders

• Avoid self-medication

• Complete the full course to prevent antibiotic resistance

N-LEVO – 500 by Floriwa Labs is a reliable and effective antibiotic solution designed to combat a wide range of bacterial infections, ensuring faster recovery and improved patient outcomes.